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Abstract: Our group has recently shown the existence of a gut microbial dysbiosis in 
systemic lupus erythematosus (SLE), supporting previous evidence involving intestinal 
bacteria in the initiation and amplification of autoimmune diseases. While several studies 
have addressed the use of dietary fibres to modify intestinal microbiota, information about 
other correlated components, such as polyphenols, is scarce. The aim of this work was to 
identify dietary components able to influence this altered microbiota in 20 SLE women and 
20 age-matched controls. Food intake was recorded by means of a food frequency 
questionnaire. The intake of fibres was calculated from Marlett tables, and Phenol-Explorer 
was used for polyphenol consumption. Results showed positive associations between 
flavone intake and Blautia, flavanones and Lactobacillus, and dihydrochalcones and 
Bifidobacterium in the SLE group. Regarding the controls, dihydroflavonols were directly 
associated with Faecalibacterium, whereas flavonol intake was inversely associated with 
Bifidobacterium. From the food sources of these polyphenols related to microbiota, orange 
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intake was directly associated with Lactobacillus and apple with Bifidobacterium in SLE, 
whilst red wine was the best contributor to Faecalibacterium variation. The association 
between common foods and particular microbial genera, reported to be decreased in SLE, 
could be of great importance for these patients.  
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1. Introduction 
Gut microbiota has been related to the modulation of the immune system and to anti-oxidant  
defence [1–3]. We have recently published the existence of a gut microbial dysbiosis in patients with 
systemic lupus erythematosus (SLE). The decrease in the ratio of Firmicutes to Bacteroidetes in SLE 
subjects [4] supports previous evidence involving intestinal bacteria in the initiation and amplification 
of inflammatory processes and autoimmune diseases [5–7]. In this regard, common clinical features 
associated with SLE, such as intestinal vasculitis, could have an influence on the observed dysbiosis. In 
relation to this, high Bacteroidetes levels have also been found in patients with inflammatory bowel 
disease [8]. In this context, it has been reported that patients with metabolic syndrome fed with a low 
fat/high carbohydrate diet suffered an increase in Bacteroides spp. and Bifidobacterium spp. [9]. Other 
previous studies have positively associated levels of Firmicutes with a low-fat/high-fibre diet [10] and 
the increase in Firmicutes/Bacteroidetes ratio with whole grain supplementation [11]. Also, it has been 
found that the microbiota of people with a long-term diet rich in animal protein and saturated fat presents 
more Bacteroides [12]. Apart from this, other bioactive compounds from diet, such as polyphenols, are 
able to modulate the intestinal microbiome [13], and have shown promising results in models of 
autoimmune diseases [14]. To date, there are few studies which have focused on the interactions between 
polyphenol intake and microbiota: evidence from animal and human studies has shown that supplementation 
with polyphenol-rich food, such as red wine [15], tea [13], cocoa [16] or blueberries [17,18], modulates 
some intestinal bacterial populations, but the results were not conclusive. While Queipo-Ortuño et al. have 
recently published changes in Proteobacteria, Fusobacteria, Firmicutes and Bacteroidetes concentrations 
in humans after dietary intervention with alcoholic beverages (red wine and gin) and de-alcoholized red  
wine [15], animal studies have found a lower proportion of Clostridium and Lactobacillus in polyphenol-
treated rats with respect to the control [19]. Moreover, the effects of cocoa flavanols remain controversial: 
an increase in Lactobacillus and Bacteroides has been described in humans [20], but evidence in animal 
studies showed a decrease of Bacteroides, Clostridium and Staphylococcus [16].  
Thus, as this imbalance is susceptible to being modified by shifting dietary patterns, the overall aim 
of this paper was the identification of dietary components associated with this altered microbiota. 
Knowledge of the interactions between diet and microbiota in SLE subjects may be useful in the future 
to establish some basis for the rational design of functional foods and dietary intervention strategies 
meant to improve the clinical manifestations of these chronic patients. 
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2. Subjects and Methods  
The study sample comprised 20 SLE patients selected from the updated Asturian Register of  
Lupus [21]. All of them fulfilled at least four of the American College of Rheumatology criteria for  
SLE [22], were women of Caucasian origin, aged between 35–70 years and had no active disease at the 
time of sampling (Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score ≤ 8). Patients 
were also asked precise questions regarding treatment received during the previous 6 months. Only those 
individuals who had not used antibiotics, glucocorticoids, immunosuppressive drugs, monoclonal 
antibodies, or other immunotherapies were recruited for the study. Eighteen patients were receiving 
antimalarial treatment, and all of them were regular consumers of nonsteroidal anti-inflammatory drugs. 
Twenty age-matched healthy women from the same population were recruited as controls.  
Ethics approval for this study (reference code AGL2010-14952; grant title “Towards a better 
understanding of gut microbiota functionality in some immune disorders”) was obtained from the 
Bioethics Committee of CSIC (Consejo Superior de Investigaciones Científicas) and from the Regional 
Ethics Committee for Clinical Research (Servicio de Salud del Principado de Asturias, nº 13/2010) in 
compliance with the Declaration of Helsinki. All determinations were performed with fully informed 
written consent from all participants involved in the study. 
2.1. Nutritional Assessment 
Dietary intake was assessed by means of an annual semi-quantitative food-frequency questionnaire 
(FFQ) of 160 items, previously validated for polyphenol intake in other samples [23]. The FFQ was 
organized by groups of food and open-ended, allowing foods consumed by the subject and not registered 
in the questionnaire to be recorded. During a personal interview, subjects were asked item-by-item 
whether they usually ate each food (daily, weekly or monthly), and, if so, how much they usually ate. 
To facilitate the recording of the quantities of food consumed, 3 different serving sizes of each cooked 
food were presented in pictures to the participants, so that they could choose from up to 7 serving sizes 
(from “less than the small one” to “more than the large one”). For some of the foods consumed, amounts 
were recorded in household units, by volume, or by measuring with a ruler. Special attention was paid 
to cooking practices, number and amount of ingredients used in each recipe, as well as questions 
concerning menu preparation (e.g., type of oil used, type of milk) and other relevant information for the 
study, such as the consumption of skin in fruit. Furthermore, variability in the consumption of some 
foods, especially fruits and vegetables, according to the season was taken into account. The consumption 
of foods was converted into energy and saturated fatty acid intake using the nutrient Food Composition 
Tables developed by the Centro de Enseñanza Superior de Nutrición Humana y Dietética (CESNID) [24]. 
Dietary fibre was determined from Marlett Food Composition Tables [25] and animal protein from the 
USDA Database [26]. The content of flavonoids in the foods consumed in the sample, with the exception 
of spices and condiments, was calculated using the Phenol-Explorer Database. This database contains 
detailed information of the polyphenol content in more than 400 foods, mainly determined by high-
performance liquid chromatography (HPLC), gas chromatography (GC), and capillary electrophoresis (CE), 
and is compiled from more than 1300 publications, being at the moment one of the main tools used in 
human studies [27]. 
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2.2. Anthropometric Measures 
Body mass index (BMI) was calculated using Quetelet formula. Weight was measured on a scale with 
an accuracy of ±100 g (Seca, Hamburg, Germany). Height was registered using a stadiometer with an 
accuracy of ±1 mm (Año-Sayol, Barcelona, Spain). Subjects stood barefoot, in an upright position and 
with the head positioned in the Frankfort horizontal plane.  
2.3. Microbiological Analyses 
Faecal DNA extraction, 16S rRNA amplification sequencing of 16S rRNA gene-based amplicons and 
the sequence-based microbiota analysis were reported elsewhere [4]. The raw sequences reported in this 
article are deposited in the NCBI Short Read Archive (SRA) (study accession number: SRP028162). 
2.4. Statistical Analysis 
Statistical analysis was performed using IBM-SPSS version 19.0 (SPSS-Inc., Chicago). Goodness of 
fit to normal distribution was analysed with the Kolmogorov-Smirnov test. Since the relative abundance 
of Lactobacillus did not fulfill this criterion, the variable was logarithmically transformed to perform the 
analysis. For descriptive purposes, mean values were presented on untransformed variables. Multivariate 
analysis, including age and energy intake, were conducted to examine the difference in the mean intake 
of animal protein, saturated fatty acids, dietary fibre and flavonoids between SLE patients and controls, 
while the Student t-test was used to evaluate the difference in consumption of the main food sources of 
flavonoids. In order to investigate the association between the intake of animal protein, saturated fatty 
acids, dietary fibre and flavonoids and faecal relative abundance of the studied microorganisms, multiple 
linear regression analysis was carried out. Age and energy intake were also included as covariates in the 
models. The main food sources of the dietary components previously related to microbiota were selected 
and placed in a multiple stepwise regression analysis to explore their independent effect. The statistical 
parameters employed were β (standardized regression coefficient) and R2 (coefficient of multiple 
determinations).The conventional probability value for significance (0.05) was used in the interpretation 
of results. Considering the standard deviation of the microbial relative abundance and the standard 
deviation of the regression errors, we could reject the null hypothesis with an estimated probability 
around 0.8 and a type I error probability of 0.05 for the three models (calculated using the software PS: 
Power and Sample Size Calculation version 3.0.43 (Vanderlbilt University, Nashville, TN, USA)). 
3. Results  
General characteristics and daily intake of dietary components previously associated with microbiota 
are compared between SLE patients and control subjects in Table 1. Both groups were similar for all the 
studied variables. 
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Table 1. Characteristics of the evaluated variables in systemic lupus erythematosus (SLE)  
and controls. 
 SLE (N = 20) Control (N = 20) Reference 
Age (year) 49.25 ± 10.71 46.95 ± 8.60 [4] 
BMI (kg·m−2)  26.11 ± 5.31 25.17 ± 4.16 [4] 
Energy (kcal·day−1) a 2189.65 ± 722.42 1858.53 ± 332.85 [4] 
Animal protein (g·day−1) a,b 104.70 ± 27.60 100.85 ± 20.86 This work 
Saturated fatty acids (g·day−1) a,b 25.19 ± 14.09 24.66 ± 6.04 [4] 
Dietary fiber (g·day−1) a,b 18.06 ± 10.04 20.32 ± 8.52 [4] 
Total flavonoids (mg·day−1) a,b 400.13 ± 259.94 436.34 ± 189.70 This work 
Anthocyanins (mg·day−1) a,b 20.81 ± 30.30 29.73 ± 30.65  
Dihydrochalcones (mg·day−1) a,b 2.70 ± 4.42 3.26 ± 3.58  
Dihydroflavonols (mg·day−1) a,b 0.34 ± 0.80 1.96 ± 2.82 *  
Flavanols (mg·day−1) a,b 298.54 ± 222.16 283.47 ± 160.21  
Flavanones (mg·day−1) a,b 38.22 ± 29.44 45.31 ± 32.81  
Flavones (mg·day−1) a,b 2.48 ± 2.39 3.96 ± 3.92  
Flavonols (mg·day−1) a,b 38.00 ± 30.26 52.05 ± 25.55  
Isoflavones (mg·day−1) a,b 5.52 ± 16.81 15.92 ± 66.13  
Multivariate analysis adjusted by a age and b energy intake; Results are presented as estimated marginal mean 
± SD; * p ≤ 0.05. 
In order to explore the association between dietary components and faecal microbiota with 
independence of age and energy intake, linear regression analysis was conducted. Animal protein, 
saturated fatty acids and dietary fibre were not associated with microbial genera in any of the studied 
groups (Table 2).  
Table 2. Linear regression analyses for daily intake of animal protein, saturated fatty acids 
(SFA) and dietary fiber on fecal microbial in patients with systemic lupus erythematosus 
(SLE) and controls. 
 Group 
Animal protein 
(g·day−1) SFA (g·day−1) Dietary fiber (g·day−1) 
R2 β R2 β R2 β 
Blautia (%) 
L 0.129 0.206 0.273 −0.874 0.109 0.129 
C 0.028 −0.117 0.016 0.031 0.046 −0.205 
Clostridium (%) 
L 0.271 0.431 0.170 0.363 0.140 −0.116 
C 0.116 0.343 0.007 0.026 0.007 −0.022 
Lactobacillus (%) L 0.041 −0.237 0.024 −0.312 0.031 0.225 
C 0.203 −0.347 0.091 −0.030 0.174 0.336 
Lactococcus (%) L 0.345 0.447 0.213 −0.193 0.218 0.150 
C 0.065 −0.210 0.029 −0.086 0.029 −0.085 
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Table 2. Cont. 
 Group Animal protein 
(g·day−1) 
SFA (g·day−1) Dietary fiber (g·day−1) 
R2 β R2 β R2 β 
Faecalibacterium (%) L 0.063 −0.111 0148 0.641 0.086 −0.232 
C 0.143 0.272 0.075 0.028 0.074 0.000 
Bacteroides (%) L 0.005 −0.026 0.017 0.232 0.118 0.439 
C 0.125 0.110 0.291 0.483 0.115 −0.045 
Bifidobacterium (%) L 0.121 −0.126 0.147 0.402 0.299 0.567 
C 0.323 −0.154 0.302 −0.046 0.371 −0.309 
L = SLE (N = 20); C = Control (N = 20); SFA = Saturated Fatty Acids; Results derived from multiple linear 
regression analysis including age and energy intake as covariates; R2: coefficient of multiple determinations;  
β: standardized regression coefficient. 
The associations found between flavonoid classes and microbiota are illustrated in Figure 1a,b. Results 
showed positive associations between flavone intake and Blautia, flavanones and Lactobacillus and 
dihydrochalcones and Bifidobacterium in SLE group. Regarding the control group, dihydroflavonols 
were directly associated with Faecalibacterium, whereas flavanol and flavonol intake were inversely 
associated with Bifidobacterium. Given the high correlation with flavonoids from foods, an additional 
stepwise regression analysis was conducted to explore the relative importance of flavanol and flavonol 
intake on Bifidobacterium. Flavonol intake was found to be an independent contributor to this microbial 
group (data not shown). To explore these associations, the main food sources of these flavonoids were 
calculated (Figure 2a,b). In SLE subjects, oranges and their products were the top contributors to both 
flavones and flavanones, while dihydrochalcones came exclusively from apple intake. In controls, 
dihydroflavonols were provided from red wine, and other foods such as tea, spinach and walnuts 
contributed to explain 45% of flavonol intake.  
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(a) 
Figure 1. Cont. 
  
β = 0.695; p = 0.006 
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(b) 
Figure 1. (a) Linear estimation trends between the intake of some classes of flavonoids and 
the proportion of selected microbial genera, in systemic lupus erythematosus patients. 
Results derived from multiple linear regression analyses including age and energy intake as 
covariates. (b) Linear estimation trends between the intake of some classes of flavonoids and 
the proportion of selected microbial genera, in controls. Results derived from multiple linear 
regression analyses including age and energy intake as covariates. * Logarithmically 
transformed variable.  
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Figure 2. Cont. 
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(b) 
Figure 2 (a) Principal food sources of the flavonoid classes previously associated with fecal 
microbiota, in systemic lupus erythematosus patients. (b) Principal food sources of the 
flavonoid classes previously associated with fecal microbiota, in controls.  
We did not find differences in the intake of any food sources, with the exception of red wine, which 
had greater consumption in controls (Table 3).  
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Table 3. Mean intake of the selected food sources of flavonoids in systemic lupus 
erythematosus (SLE) patients and controls. 
 SLE (N = 20) Control (N = 20) 
Orange (g·day−1) 58.43 ± 72.24 34.51 ± 42.75 
Orange juice (g·day−1) 17.94 ± 33.69 51.51 ± 73.53 
Lettuce (g·day−1) 50.63 ± 30.19 50.22 ± 42.66 
Watermelon (g·day−1) 10.79 ± 19.11 7.01 ± 13.83 
Kiwi (g·day−1) 21.19 ± 29.50 25.11 ± 62.61 
Tomato (g·day−1) 84.06 ± 51.58 72.77 ± 48.13 
Apple (g·day−1) 77.81 ± 81.87 58.72 ± 63.59 
Lentils (g/day) 8.02 ± 5.12 9.31 ± 7.69 
Celery (g·day−1) 0.18 ± 0.80 0.45 ± 1.51 
Red wine (mL·day−1) 6.79 ± 14.37 34.20 ± 52.34 * 
White wine (mL·day−1) 1.79 ± 7.99 8.95 ± 34.30 
Tea (mL·day−1) 51.52 ± 156.22 93.82 ± 172.59 
Spinach (g·day−1) 3.01 ± 6.15 4.44 ± 5.76 
Walnuts (g·day−1) 6.014 ± 11.24 7.75 ± 10.77 
White beans (g·day−1) 6.61 ± 4.20 6.82 ± 7.13 
Broccoli (g·day−1) 6.16 ± 10.63 7.64 ± 9.47 
Asparagus (g·day−1) 9.66 ± 9.96 8.80 ± 14.87 
Green beans (g·day−1) 8.08 ± 15.56 11.59 ± 12.36 
Derived from Students’ t-test; Results are presented as mean ± SD; * p ≤ 0.05. 
From foods, orange and apple intake explained 38% and 44% of relative abundance for Lactobacillus 
and Bifidobacterium, respectively, in SLE subjects, whereas red wine was positively associated with 
Faecalibacterium in the control (Table 4).  
Table 4. Results from a stepwise multiple regression analysis for prediction of relative 
abundance of fecal microbiota by the intake of the principal food sources of flavonoids in 
systemic lupus erythematosus (SLE) and control subjects. 
 Predictors  R2 β p 
SLE (N = 20)     
Lactobacillus a Orange 0.383 0.619 0.004 
Bifidobacterium b Apple  0.437 0.661 0.001 
Controls (N = 20)     
Faecalibacterium c Red wine 0.264 0.514 0.024 
Results derived from multiple stepwise regression analysis; R2: coefficient of multiple determinations;  
β: standardized regression coefficient; Variables included in the model: a age, energy, orange and orange juice intake; 
b age, energy, and apple intake; c age, energy and red and white wine intake. Only significant results are presented. 
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4. Discussion  
Systemic lupus erythematosus is a multisystemic chronic inflammatory disease that is autoimmune 
in nature. Although the cause of this pathology is unknown, accumulating evidence suggests that gut 
microbiota might impact both disease symptoms and progression. To date, there is no clear evidence 
about the impact of correcting dysbiosis in these patients, but the identification of dietary factors able to 
modify the microbial balance could be important for future investigations. With this aim, we proceeded 
to analyse the association among dietary components and microbiota.  
Most previous works about the impact of diet on this disease are focused on the immunomodulatory 
effects of the supplementation, or restriction of some dietary components, including calorie, protein or 
fat intake [28–30], on the basis that the fact of having a pathological condition could implicate changes 
in food supply. However, the comparison of the global intake between SLE patients and controls 
presented in this study reveals that the nutritional intake of both groups is similar and, therefore, there is 
no dietary constituent significantly raised or lowered in relation to the presence of the pathology.  
Despite previous evidence from intervention studies with high-fat diets suggesting that excessive fat 
intake leads to changes in the proportion of Bacteroides and Clostridium [31], our results do not support 
a relationship between fat intake and these bacterial groups in humans with well-balanced diets. Also, 
we did not find differences in faecal microbiota according to the intake of animal protein or fibre intake. 
It is possible that the amounts of these dietary components in our sample were insufficient to have an 
impact on faecal microbiota or, as some authors have suggested, that the food combinations of a diet 
modify the effect of dietary single components [32]. In this regard, it has been reported that the negative 
effects of high-fat diets were different when fat was administrated with orange juice vs. water or glucose 
solution [32], probably due to the high levels of antioxidant bioactive compounds, such as flavonoids, 
present in this beverage, and proposed in recent years as gut microbiota modulators [33].  
Likely, the most important finding of this study is the identification of a direct association, in SLE 
patients, between flavanones, flavones and dihydrochalcones, coming from a regular diet, and faecal 
levels of Blautia, Lactobacillus and Bifidobacterium, together with the detection of an inverse 
association between flavonol intake and faecal levels of Bifidobacterium, and positive one for 
dihydroflavonols and Faecalibacterium in control subjects. The positive association between orange 
flavanones and Lactobacillus proportions found in this study is not in accordance with previous evidence 
of the antimicrobial activity of these flavonoids [34]. Nevertheless, we have limited information about 
the role of individual flavonoids on microbiota to be able to compare our results, taking into 
consideration that results from in vitro studies cannot be directly extrapolated to what occurs in the 
physiological context of the intestinal ecosystem, and intervention work often involves very high doses 
of individual compounds, or high doses of polyphenol rich foods (tea, coffee or cocoa being the most 
frequent), which are not representative of what occurs in a regular diet.  
It is known that the natural presence of flavonoids within foodstuffs and their interaction with other dietary 
components, such as fibres, may modify the level of polyphenols available to the gut microbiota [35]. In this 
sense, it is possible that dihydrochalcones from apples, along with dietary fibre, are degraded by 
Bifidobacterium, promoting its growth. This effect of apple polyphenols, previously reported in animal 
models and humans [36,37], should be of special interest for SLE patients given the immunomodulatory 
effect attributed to some strains of this bacterial genus [38], such as B. bifidum LMG13195, a strain that 
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promoted the induction of regulatory T cells (Tregs), expressing chemokine receptors and potentially 
favouring mucosal homeostasis [1,2]. Dihydrochalcones have also been shown to influence the 
commensal intestinal microbiota, increasing the levels of some bacteria in the gut, such as Lactobacillus 
species [39]. As these beneficial groups of microorganisms trigger immunomodulatory processes in the 
host through the action of metabolites or other secreted compounds, administration of dihydrochalcones 
might have an impact on host immunity, although this assumption deserves further work [40]. 
Even though flavones were widely distributed among fruits and vegetables in the sample (oranges, 
lettuce, watermelon, kiwi, tomato, apple, etc.), none of their sources were identified as independent 
predictors of Blautia proportion, so we speculate that the observed associations could be attributable to 
the combination of all flavone-rich foods present in a whole diet, unlike flavanones and 
dihydrochalcones, which are provided almost exclusively by oranges and apples, respectively. Since 
Clostridium-dependent induction of Tregs may be required for maintaining immune homeostasis, and 
considering that Blautia belongs to Clostridium cluster XIVa, which promotes Treg cell accumulation, 
this result could also be of interest for other autoimmune diseases [41]. 
It is noteworthy that the associations observed in SLE patients did not appear in the controls, which 
means that in addition to the differences in the food sources of these compounds, it is possible that the 
variability in the composition of gut microbiota between groups may involve different diet-microbiota 
associations [42,43], or that subjects with a well-balanced immune system could be less susceptible to 
the effect of dietary components than subjects with altered immune responses. The influence of red wine 
on Faecalibacterium concentrations has not been previously described, but it is in agreement with the 
reported changes in the phylum Firmicutes after red wine administration [15], supporting the hypothesis 
about the prebiotic effect of moderate red wine consumption [19]. On the other hand, the inverse 
association between flavonols and Bifidobacterium is in accordance with data from in vitro studies [44]. 
It is possible that the lack of association in SLE patients may be due to the low intake of red wine in this 
group compared to the controls (5.9 ± 8.9 vs. 35.1 ± 9.1 mL·day−1 respectively). Since 80% of the SLE 
sample did not consume red wine, we had no statistical power to detect any association with this beverage.  
5. Conclusions  
Finally, although epidemiological analyses do not establish causality, our findings support the 
association between polyphenols from a regular diet and faecal microbiota. The association between 
common foods, such as oranges and apples, with specific microorganisms reported to be decreased in 
SLE could be of great importance for these patients. It could also be of great interest for future studies 
to explore the functional changes occurring in SLE intestines and how they affect the various impacts of 
dietary flavonoids on microbiota for a healthy population. Even when causality between changes in the 
Firmicutes/Bacteroidetes ratio and lupus progression requires further validation, these results will 
generate new hypotheses to test dietary strategies to correct dysbiosis in this pathology, suggesting a 
new therapeutic approach to treat autoimmunity diseases.  
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